1. Home
  2. NUTX vs PMN Comparison

NUTX vs PMN Comparison

Compare NUTX & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUTX
  • PMN
  • Stock Information
  • Founded
  • NUTX 2011
  • PMN 2004
  • Country
  • NUTX United States
  • PMN Canada
  • Employees
  • NUTX N/A
  • PMN N/A
  • Industry
  • NUTX Retail: Computer Software & Peripheral Equipment
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • NUTX Technology
  • PMN Health Care
  • Exchange
  • NUTX Nasdaq
  • PMN Nasdaq
  • Market Cap
  • NUTX 691.6M
  • PMN 16.0M
  • IPO Year
  • NUTX N/A
  • PMN N/A
  • Fundamental
  • Price
  • NUTX $113.13
  • PMN $0.44
  • Analyst Decision
  • NUTX Strong Buy
  • PMN Strong Buy
  • Analyst Count
  • NUTX 2
  • PMN 3
  • Target Price
  • NUTX $262.50
  • PMN $4.33
  • AVG Volume (30 Days)
  • NUTX 277.3K
  • PMN 5.1M
  • Earning Date
  • NUTX 08-07-2025
  • PMN 08-07-2025
  • Dividend Yield
  • NUTX N/A
  • PMN N/A
  • EPS Growth
  • NUTX N/A
  • PMN N/A
  • EPS
  • NUTX 12.01
  • PMN N/A
  • Revenue
  • NUTX $624,284,633.00
  • PMN N/A
  • Revenue This Year
  • NUTX $65.82
  • PMN N/A
  • Revenue Next Year
  • NUTX $4.98
  • PMN N/A
  • P/E Ratio
  • NUTX $9.49
  • PMN N/A
  • Revenue Growth
  • NUTX 141.25
  • PMN N/A
  • 52 Week Low
  • NUTX $5.25
  • PMN $0.38
  • 52 Week High
  • NUTX $184.28
  • PMN $2.22
  • Technical
  • Relative Strength Index (RSI)
  • NUTX 44.53
  • PMN 46.15
  • Support Level
  • NUTX $108.25
  • PMN $0.48
  • Resistance Level
  • NUTX $140.42
  • PMN $1.25
  • Average True Range (ATR)
  • NUTX 11.84
  • PMN 0.09
  • MACD
  • NUTX -0.22
  • PMN 0.00
  • Stochastic Oscillator
  • NUTX 23.52
  • PMN 6.90

About NUTX Nutex Health Inc.

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: